| Term 
 
        | 4 ways to cause vasodilation |  | Definition 
 
        | Increase cGMP Dephosphorylation of myosin light chains
 (nitrates, PDE5 inhibitors)
 
 Decrease intracellular Ca2+
 Decrease Ca which facilitates myosin light chain kinase
 (calcium channel blockers)
 
 Stabilize/prevent depolarization of smooth muscle cell (K+ channel agonists)
 Increase K+ efflux, hyperpolarize
 (K+ channel agonists)
 
 Increase cAMP
 (β2 agonists)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - dhp calcium channel blocker MOA - inhibit L-type Ca channels (bind during depolarization)
 where: peripheral vessels
 *dilates blood vessels (arteries > veins)
 Decreases: peripheral resistance, BP
 AE - reflex tachycardia, gingival hyperplasia
 NOTE - only used as extended release formulations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - nondhp calcium channel blocker MOA - inhibit L-type Ca channels
 where: cardiac tissue
 Decreases: SA/AV node activity, contractility, BP
 AE - bradycardia, heart block, constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - organic nitrate MOA - NO -> guanylyl cyclase -> INCREASE cGMP -> dephosphorylate myosin light chains
 where: peripheral vessels, GI, bronchi
 *dilates blood vessels (veins > arteries)
 Increases: cGMP
 Decreases: peripheral resistance, BP, venous return (bc pooling of blood)
 AE - orhtostatic HTN, tolerance
 |  | 
        |  | 
        
        | Term 
 
        | minoxidil 
 (Lotinen)(Rogaine)
 |  | Definition 
 
        | class - K+ channel agonist MOA - activate K+ channels in blood vessels causing hyperpolarization (K+ moves out of cells) making it harder for the cells to depolarize and contract
 where: peripheral vessels
 *dilates blood vessels (arteries > veins)
 Decreases: peripheral resistance
 Tx - hair growth
 AE - T wave changes on an ECG, hypertrichosis (hair)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - phosphodiesterase(5) inhibitor MOA - inhibits PDE5
 where: corpus cavernosum, rods/cones, lungs
 Increases: cGMP
 Decreases: BP
 Tx - ED, pulmonary HTN
 AE - blue/green discrimination, nasal congestion
 |  | 
        |  |